AbbVie
ABBV
#25
Rank
A$755.27 B
Marketcap
A$427.28
Share price
-0.39%
Change (1 day)
27.67%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): A$8.50

According to AbbVie's latest financial reports the company's current EPS (TTM) is A$8.54. In 2025 the company made an earnings per share (EPS) of A$3.46 a decrease over its 2024 EPS that were of A$3.54.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$8.50145.88%
2025A$3.46-2.26%
2024A$3.54-11.86%
2023A$4.01-58.95%
2022A$9.772.49%
2021A$9.53121.58%
2020A$4.30-44.7%
2019A$7.7845.84%
2018A$5.339.72%
2017A$4.86-9.54%
2016A$5.3816.28%
2015A$4.62184.1%
2014A$1.63-57.15%
2013A$3.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.04-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.09 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.37 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.44-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.52-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.60-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.39 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$4.20-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$10.17 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA